Clinical trial

Cardiovascular Events in GnRH Agonist vs. Antagonist

NCT04182594

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-01-17

PhasePHASE2

Study timeline

Study start (estimated)2020-01-17Date precision: day

Registry last updated2019-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hormone Sensitive Prostate Cancerunresolved

Prostate Cancerunresolved

Cardiac Eventunresolved

Interventions

DegarelixDRUG · verified · RxNorm: degarelix

GnRH agonistDRUG

Sponsors & collaborators

Rabin Medical Centerlead sponsor

Ferring Pharmaceuticalscollaborator

Mapped research locations

Petah TikvaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04182594 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.